CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 85 filers reported holding CHEMOCENTRYX INC in Q3 2017. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $273,000 | – | 29,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 8,596,772 | $58,716,000 | 11.42% |
| WASATCH ADVISORS LP | 2,536,928 | $17,327,000 | 0.18% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,810,456 | $12,365,000 | 0.11% |
| BLUE ARROW CAPITAL MANAGEMENT LLC | 140,000 | $956,000 | 0.11% |
| Artal Group S.A. | 400,000 | $2,732,000 | 0.10% |
| Artal Group S.A. | 400,000 | $2,732,000 | 0.10% |
| Gruss Capital Management LP | 483,000 | $3,299,000 | 0.09% |
| Fernwood Investment Management, LLC | 10,000 | $68,000 | 0.06% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1,276,833 | $8,721,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 120,000 | $820,000 | 0.02% |